Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di Bruce I Sachs. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che Bruce I Sachs ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
US:VRTX / Vertex Pharmaceuticals Incorporated Director 45.000
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da Bruce I Sachs. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da Bruce I Sachs come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 3.366 45.000 8,08 389,84 1.312.201 17.542.800
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 1.634 41.634 4,08 389,36 636.214 16.210.614
2024-08-02 2024-08-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.295 40.000 -11,69 508,00 -2.689.860 20.320.000
2024-08-02 2024-08-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5.295 45.295 13,24 125,71 665.634 5.694.034
2024-05-24 2024-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7.073 40.000 -15,03 448,00 -3.168.704 17.920.000
2024-05-24 2024-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.073 47.073 17,68 93,51 661.396 4.401.796
2023-11-08 2023-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11.250 40.000 -21,95 385,00 -4.331.250 15.400.000
2023-11-08 2023-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 11.250 51.250 28,12 127,54 1.434.825 6.536.425
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.842 40.000 -8,76 357,29 -1.372.708 14.291.600
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.711 43.842 -11,53 356,75 -2.037.399 15.640.634
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.697 49.553 -3,31 355,54 -603.351 17.618.074
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 11.250 51.250 28,12 127,54 1.434.825 6.536.425
2023-04-14 2023-04-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -1.210 40.000 -2,94
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -8.026 41.210 -16,30 327,48 -2.628.354 13.495.451
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.357 49.236 -17,38 326,46 -3.381.146 16.073.585
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.917 59.593 -4,67 325,65 -949.921 19.406.460
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 21.300 62.510 51,69 72,14 1.536.582 4.509.471
2023-02-02 2023-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.200 41.210 -2,83 325,01 -390.012 13.393.662
2023-02-02 2023-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.200 42.410 2,91 72,14 86.568 3.059.457
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 4.462 4.462
2022-04-18 2022-04-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 151 13.824 1,11 289,41 43.750 4.000.661
2022-01-19 2022-01-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 190 13.672 1,41 230,58 43.750 3.152.568
2021-10-18 2021-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 240 13.483 1,81 182,07 43.750 2.454.777
2021-08-04 2021-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 15.000 41.210 57,23 197,91 2.968.650 8.155.871
2021-07-16 2021-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 221 13.242 1,70 198,00 43.750 2.621.977
2021-05-04 2021-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 6.067 6.067
2021-04-16 2021-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 199 13.021 1,55 220,17 43.750 2.866.910
2021-01-19 2021-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 194 12.823 1,53 225,99 43.750 2.897.787
2020-11-12 2020-11-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 3.905 26.210 17,51 218,79 854.375 5.734.486
2020-11-12 2020-11-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4.270 22.305 23,68 217,49 928.682 4.851.114
2020-11-12 2020-11-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 6.825 18.035 60,88 216,47 1.477.408 3.904.036
2020-10-19 2020-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 196 12.629 1,58 222,81 43.750 2.813.877
2020-07-17 2020-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 155 12.433 1,26 292,77 45.453 3.639.917
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 4.527 4.527
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -22.500 0 -100,00
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -22.500 0 -100,00
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.960 11.210 -20,89 272,46 -806.482 3.054.277
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.232 14.170 -30,55 271,63 -1.692.798 3.848.997
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.889 20.402 -22,40 270,49 -1.592.916 5.518.537
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.751 26.291 -37,46 269,53 -4.245.367 7.086.213
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11.568 42.042 -21,58 268,65 -3.107.743 11.294.583
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.600 53.610 -4,63 267,50 -695.500 14.340.675
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 22.500 56.210 66,75 81,54 1.834.650 4.583.363
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 22.500 33.710 200,71 59,55 1.339.875 2.007.430
2020-04-17 2020-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 179 12.277 1,48 258,56 46.250 3.174.453
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 11.210 -0,88 235,40 -23.540 2.638.834
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -900 11.310 -7,37 234,15 -210.735 2.648.236
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.800 12.210 -12,85 233,13 -419.634 2.846.517
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.200 14.010 -7,89 232,04 -278.448 3.250.880
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.200 15.210 -7,31 230,87 -277.044 3.511.533
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 16.410 -2,96 229,90 -114.950 3.772.659
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 16.910 -3,43 228,33 -136.998 3.861.060
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 17.510 -1,68 227,66 -68.298 3.986.327
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.644 17.810 -24,06 227,01 -1.281.244 4.043.048
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.198 23.454 -15,18 226,32 -950.091 5.308.109
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.858 27.652 -6,30 224,98 -418.013 6.221.147
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.700 29.510 -5,45 224,02 -380.834 6.610.830
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 20.000 31.210 178,41 53,85 1.077.000 1.680.658
2020-01-17 2020-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 200 12.099 1,68 231,55 46.250 2.801.421
2019-10-17 2019-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 264 11.899 2,26 175,50 46.250 2.088.242
2019-07-17 2019-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 257 11.635 2,26 176,39 45.371 2.052.348
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 1.801 11.378 18,81
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 6.659 6.659
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -1.801 11.210 -13,84
2019-04-17 2019-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 247 9.577 2,65 182,28 45.000 1.745.707
2019-01-16 2019-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 243 9.330 2,68 184,90 45.000 1.725.152
2019-01-02 2018-12-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -10.000 13.011 -43,46
2018-12-07 2018-12-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10.000 0 -100,00
2018-12-07 2018-12-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 23.011 76,86 34,24 342.400 787.897
2018-10-17 2018-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 251 9.087 2,84 179,29 45.000 1.629.175
2018-07-18 2018-07-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 249 8.836 2,90 180,97 45.000 1.599.019
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 2.188 8.587 34,19
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3.229 3.229
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -2.188 13.011 -14,40
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 1.801 15.199 13,44
2018-04-18 2018-04-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 280 6.399 4,57 160,89 45.000 1.029.561
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 262 6.119 4,47 157,50 41.250 963.816
2018-01-17 2017-12-20 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -10.000 13.398 -42,74
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 265 5.858 4,75 155,44 41.250 910.500
2017-07-19 2017-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 317 5.592 6,01 130,15 41.250 727.823
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 2.941 5.275 125,99
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 5.295 5.295
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -2.941 23.398 -11,17
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2.188 26.339 9,06
2017-04-19 2017-04-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 360 2.334 18,24 114,58 41.250 267.458
2017-01-19 2017-01-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 508 1.974 34,67 81,16 41.250 160.229
2016-10-19 2016-10-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 516 1.466 54,25 80,01 41.250 117.293
2016-07-19 2016-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 461 950 94,25 89,45 41.250 85.015
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 7.073 7.073
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2.941 24.151 13,87 0,01 29 242
2016-04-19 2016-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 489 489 87,60 42.860 42.860
2015-08-05 2015-08-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2015-08-05 2015-08-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 21.210 -32,04 140,13 -1.401.300 2.972.157
2015-08-05 2015-08-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 31.210 47,15 34,24 342.400 1.068.630
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22.500 22.500
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.375 21.210 -6,09 136,14 -187.192 2.887.529
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -8.625 22.585 -27,64 135,42 -1.167.998 3.058.461
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 31.210 47,15 29,89 298.900 932.867
2015-03-20 2015-03-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2015-03-20 2015-03-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 21.210 -32,04 130,13 -1.301.300 2.760.057
2015-03-20 2015-03-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 31.210 47,15 29,89 298.900 932.867
2015-01-22 2015-01-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -139 0 -100,00
2015-01-22 2015-01-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -139 21.210 -0,65 125,00 -17.375 2.651.250
2015-01-22 2015-01-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 139 21.349 0,66 28,40 3.948 606.312
2015-01-13 2015-01-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -9.861 139 -98,61
2015-01-13 2015-01-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9.861 21.210 -31,74 125,04 -1.233.019 2.652.098
2015-01-13 2015-01-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 9.861 31.071 46,49 28,40 280.052 882.416
2014-12-01 2014-11-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2014-12-01 2014-11-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 21.210 -32,04 120,03 -1.200.300 2.545.836
2014-12-01 2014-11-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 31.210 47,15 28,40 284.000 886.364
2014-11-07 2014-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -9.900 0 -100,00
2014-11-07 2014-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9.900 21.210 -31,82 115,21 -1.140.579 2.443.604
2014-11-07 2014-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 9.900 31.110 46,68 29,84 295.416 928.322
2014-11-05 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -100 9.900 -1,00
2014-11-05 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 21.210 -0,47 111,86 -11.186 2.372.551
2014-11-05 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 100 21.310 0,47 29,84 2.984 635.890
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 21.210 -0,47 115,45 -11.545 2.448.694
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.400 21.310 -17,11 114,23 -502.612 2.434.241
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.200 25.710 -11,07 113,47 -363.104 2.917.314
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.300 28.910 -7,37 112,47 -258.681 3.251.508
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 31.210 47,15 29,84 298.400 931.306
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -20.000 0 -100,00
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.684 21.210 -11,23 112,80 -302.755 2.392.488
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -17.316 23.894 -42,02 112,03 -1.939.911 2.676.845
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 20.000 41.210 94,30 34,32 686.400 1.414.327
2014-06-03 2014-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22.500 22.500
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 21.210 -2,30 76,57 -38.285 1.624.050
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.000 21.710 -12,14 75,25 -225.750 1.633.678
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.750 24.710 -10,01 74,47 -204.792 1.840.154
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.450 27.460 -8,19 73,53 -180.148 2.019.134
2014-02-24 2014-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.200 29.910 -9,66 84,13 -269.216 2.516.328
2014-02-24 2014-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.800 33.110 -10,30 83,65 -317.870 2.769.652
2014-02-24 2014-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.300 36.910 -3,40 82,51 -107.263 3.045.444
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 38.210 -1,04 86,91 -34.764 3.320.831
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.500 38.610 -3,74 85,87 -128.805 3.315.441
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 40.110 -1,47 84,90 -50.940 3.405.339
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.800 40.710 -12,47 83,89 -486.562 3.415.162
2013-12-26 2013-12-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.200 46.510 -2,52 73,45 -88.140 3.416.160
2013-12-26 2013-12-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7.100 47.710 -12,95 72,95 -517.945 3.480.444
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 54.810 -0,36 67,15 -13.430 3.680.492
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.700 55.010 -3,00 66,25 -112.625 3.644.412
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.900 56.710 -7,95 65,35 -320.215 3.705.998
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -800 61.610 -1,28 64,21 -51.368 3.955.978
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -700 62.410 -1,11 63,10 -44.170 3.938.071
2013-10-25 2013-10-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.800 63.110 -8,42 77,17 -447.586 4.870.199
2013-10-25 2013-10-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.500 68.910 -3,50 76,80 -192.000 5.292.288
2013-09-26 2013-09-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.500 71.410 -3,38 75,23 -188.075 5.372.174
2013-09-26 2013-09-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.800 73.910 -7,28 74,86 -434.188 5.532.903
2013-09-03 2013-08-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 79.710 -0,75 77,97 -46.782 6.214.989
2013-09-03 2013-08-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.010 80.310 -6,96 77,29 -464.513 6.207.160
2013-09-03 2013-08-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.690 86.320 -1,92 76,55 -129.370 6.607.796
2013-07-26 2013-07-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 88.010 -0,68 87,03 -52.218 7.659.510
2013-07-26 2013-07-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.700 88.610 -2,96 85,89 -231.903 7.610.713
2013-07-26 2013-07-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.000 91.310 -5,19 85,10 -425.500 7.770.481
2013-06-24 2013-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.700 96.310 -2,73 76,53 -206.631 7.370.604
2013-06-24 2013-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.500 99.010 -4,35 75,85 -341.325 7.509.908
2013-06-24 2013-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.100 103.510 -1,05 74,81 -82.291 7.743.583
2013-06-04 2013-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22.500 22.500
2013-05-23 2013-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.262 104.610 -3,91 80,63 -343.645 8.434.704
2013-05-23 2013-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.538 108.872 -1,39 79,50 -122.271 8.655.324
2013-05-23 2013-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.500 110.410 -2,21 78,48 -196.200 8.664.977
2013-05-16 2013-05-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale -60.000 112.910 -34,70 81,15 -4.869.000 9.162.646
2013-05-08 2013-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7.000 172.910 -3,89 77,41 -541.870 13.384.963
2013-05-08 2013-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.300 179.910 -0,72 76,19 -99.047 13.707.343
2012-06-01 2012-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22.500 22.500
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)